Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C19H18N4O3S2 and a molecular weight of approximately 414.5 g/mol. It contains a thiadiazole ring substituted with a mercapto group and is structurally related to beta amino acids and derivatives[1][3][5]. The compound has been catalogued in several chemical databases (DrugBank DB07987; PubChem CID 4369082), but there are no approved medical indications or clinical trial data available for this molecule as of now[1][3]. Its mechanism of action and pharmacological properties have not been described in public sources. It is considered an experimental research chemical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [2-(5-Mercapto-[1,3,4]thiadiazol-2-ylcarbamoyl)-1-phenyl-ethyl]-carbamic acid benzyl ester.